Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?

Suhas Ganesh, Jose Cortes-Briones, Ashley M. Schnakenberg Martin, Patrick D Skosnik, Deepak C D’Souza, Mohini Ranganathan
doi: https://doi.org/10.1101/2021.05.17.21257345

Article Information

doi 
https://doi.org/10.1101/2021.05.17.21257345
History 
  • May 19, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Suhas Ganesh1,2,
  2. Jose Cortes-Briones1,2,
  3. Ashley M. Schnakenberg Martin1,2,
  4. Patrick D Skosnik1,2,
  5. Deepak C D’Souza1,2 and
  6. Mohini Ranganathan*,1,2
  1. 1Department of Psychiatry, Yale University School of Medicine
  2. 2VA Connecticut Healthcare System, West Haven, CT 06516
  1. ↵*Corresponding Author Corresponding Author Contact Information: Mohini Ranganathan, Associate Professor, Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System/116A, 950 Campbell Ave, West Haven, CT 06516, Email: Mohini.Ranganathan{at}yale.edu Tel: 203-932-5711 X 2546, Fax: 203-937-4860
Back to top
Posted May 19, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?
Suhas Ganesh, Jose Cortes-Briones, Ashley M. Schnakenberg Martin, Patrick D Skosnik, Deepak C D’Souza, Mohini Ranganathan
medRxiv 2021.05.17.21257345; doi: https://doi.org/10.1101/2021.05.17.21257345
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area